Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-27

FDA Approved: ALLI — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for ALLI (orlistat) submitted by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLI (orlistat)

Snippet

SUPPL AP for ALLI (ORLISTAT)